Exploring the impact of a digital health tool on patients' interaction with community pharmacists: A pilot randomized controlled study

被引:0
|
作者
Qudah, Bonyan [1 ]
Chewning, Betty [2 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, 1685 Highland Ave, Madison, WI 53705 USA
[2] Univ Wisconsin, Sch Pharm, Dept Social & Adm Sci, 777 Highland Ave, Madison, WI 53705 USA
来源
关键词
Patient-reported outcomes; Digital health intervention; Patient participation; Patient-pharmacist communication; Patient concerns; Medication-related problems; Community pharmacy; MEDICAL CONSULTATIONS; COMMUNICATIVE STYLES; ADHERENCE; PARTICIPATION; QUESTION; KNOWLEDGE; BARRIERS; OUTCOMES; THERAPY; ISSUES;
D O I
10.1016/j.sapharm.2024.06.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The use of digital Patient- Reported Outcomes (PRO) tools has been shown to enhance the exchange of information and shared decision-making in medical encounters. However, their influence on patient-pharmacist interactions has not yet been explored. Objectives: This study aimed to examine the impact of RxTalk (TM), a digital PRO tool, in supporting the communication between patients and pharmacists compared to usual care. Methods: Intervention: RxTalk (TM) was developed to collect information about medication adherence and beliefs, using a tablet computer. Study design: A pilot randomized controlled study was conducted at a community pharmacy in Wisconsin, USA. Sixty patients were randomized to either the intervention group who used RxTalk (TM) during medication pick-up or the control group who did not use the tool. Patients who used RxTalk (TM) received paper copies of their responses which were also shared with pharmacists. The consultation was audio-recorded for both groups and coded using the Active Patient Participation Coding scale. Follow-up phone interviews were conducted with both groups within one week of enrollment. Results: Patient tapes were analyzed. In the unadjusted model, patients in the intervention group had a higher active participation rate (p = 0.004) and raised significantly more concerns during consultations (p < 0.001) compared to the control group. Pharmacists asked twice as many questions while counseling patients in the intervention group compared to the control group (p < 0.001). After controlling for patients' demographics and pharmacists' questions, there was a statistical difference between the two patient groups in their odds of expressing at least one concern utterance. Conclusion: This pilot study suggests that collecting PRO from patients with chronic illnesses and providing results to pharmacists and patients can help patients express their health and medication concerns. RxTalk (TM) would be useful for pharmacists who wish to improve the recognition and management of medication-related problems.
引用
收藏
页码:986 / 994
页数:9
相关论文
共 50 条
  • [1] A Systematic Review of Randomized Controlled Trials of Telehealth and Digital Technology Use by Community Pharmacists to Improve Public Health
    Crilly, Philip
    Kayyali, Reem
    PHARMACY, 2020, 8 (03)
  • [2] Exploring the Impact of a Mobile Health Solution for Postpartum Pelvic Floor Muscle Training: Pilot Randomized Controlled Feasibility Study
    Dufour, Sinead
    Fedorkow, Donna
    Kun, Jessica
    Deng, Shirley Xiaoxuan
    Fang, Qiyin
    JMIR MHEALTH AND UHEALTH, 2019, 7 (07):
  • [4] The impact of medication review by Belgian community pharmacists on adherence, a pilot study
    De Wulf, Isabelle
    Wuyts, Joke
    Maesschalck, Joris
    Foulon, Veerle
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (02) : 607 - 607
  • [5] Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial
    Brook, O
    van Hout, H
    Nieuwenhuyse, H
    Heerdink, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (01) : 1 - 9
  • [6] Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial
    Sharp, Lisa K.
    Tilton, Jessica J.
    Touchette, Daniel R.
    Xia, Yinglin
    Mihailescu, Daniel
    Berbaum, Michael L.
    Gerber, Ben S.
    PHARMACOTHERAPY, 2018, 38 (01): : 58 - 68
  • [7] Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
    Elliott, Lindsay S.
    Henderson, John C.
    Neradilek, Moni B.
    Moyer, Nicolas A.
    Ashcraft, Kristine C.
    Thirumaran, Ranjit K.
    PLOS ONE, 2017, 12 (02):
  • [8] Peripartum Management of Gestational Diabetes Using a Digital Health Care Service: A Pilot, Randomized Controlled Study
    Sung, Ji-Hee
    Lee, Da Young
    Min, Kyoung Pil
    Park, Cheol-Young
    CLINICAL THERAPEUTICS, 2019, 41 (11) : 2426 - 2434
  • [9] Recruiting Student Health Coaches to Improve Digital Blood Pressure Management: Randomized Controlled Pilot Study
    Vasti, Elena
    Pletcher, Mark J.
    JMIR FORMATIVE RESEARCH, 2020, 4 (08)
  • [10] Digital Health and Community Health Worker Support for Diabetes Management: a Randomized Controlled Trial
    Whitehouse, Christina R.
    Knowles, Molly
    Long, Judith A.
    Mitra, Nandita
    Volpp, Kevin G.
    Xu, Chang
    Sabini, Carolyn
    Gerald, Norma
    Estrada, Irene
    Jones, Denerale
    Kangovi, Shreya
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (01) : 131 - 137